PTO- 1478 |
Approved for use through 10/31/2024. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 97394650 |
Filing Date: 05/04/2022 |
Input Field |
Entered |
TEAS Plus | YES |
---|---|
MARK INFORMATION | |
*MARK | GUTCHECK |
*STANDARD CHARACTERS | YES |
USPTO-GENERATED IMAGE | YES |
LITERAL ELEMENT | GUTCHECK |
*MARK STATEMENT | The mark consists of standard characters, without claim to any particular font style, size, or color. |
REGISTER | Principal |
APPLICANT INFORMATION | |
*OWNER OF MARK | VIVANTE HEALTH, INC. |
*MAILING ADDRESS | 2450 Holcombe Blvd. |
*CITY | Houston |
*STATE (Required for U.S. applicants) |
Texas |
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
*ZIP/POSTAL CODE (Required for U.S. and certain international addresses) |
77021 |
*EMAIL ADDRESS | XXXX |
LEGAL ENTITY INFORMATION | |
*TYPE | CORPORATION |
* STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION | Delaware |
GOODS AND/OR SERVICES AND BASIS INFORMATION | |
*INTERNATIONAL CLASS | 044 |
*IDENTIFICATION | Medical diagnostic testing, monitoring and reporting services |
*FILING BASIS | SECTION 1(a) |
FIRST USE ANYWHERE DATE | At least as early as 05/04/2022 |
FIRST USE IN COMMERCE DATE | At least as early as 05/04/2022 |
SPECIMEN FILE NAME(S) | |
ORIGINAL PDF FILE | SPE0-26001700126c100098e4 15884f486a59-202205041324 28869077_._website2.pdf |
CONVERTED PDF FILE(S) (1 page) |
\\TICRS\EXPORT18\IMAGEOUT 18\973\946\97394650\xml1\ FTK0003.JPG |
ORIGINAL PDF FILE | SPE0-26001700126c100098e4 15884f486a59-202205041324 28869077_._websiteshot.pdf |
CONVERTED PDF FILE(S) (1 page) |
\\TICRS\EXPORT18\IMAGEOUT 18\973\946\97394650\xml1\ FTK0004.JPG |
SPECIMEN DESCRIPTION | Screenshot from website showing use of the mark |
WEBPAGE URL | http://vivantehealth.com/ |
WEBPAGE DATE OF ACCESS | 05/04/2022 |
ADDITIONAL STATEMENTS INFORMATION | |
*TRANSLATION (if applicable) |
|
*TRANSLITERATION (if applicable) |
|
*CLAIMED PRIOR REGISTRATION (if applicable) |
|
*CONSENT (NAME/LIKENESS) (if applicable) |
|
*CONCURRENT USE CLAIM (if applicable) |
|
ATTORNEY INFORMATION | |
NAME | Eric P Mirabel |
ATTORNEY DOCKET NUMBER | GutCheck |
ATTORNEY BAR MEMBERSHIP NUMBER | XXX |
YEAR OF ADMISSION | XXXX |
U.S. STATE/ COMMONWEALTH/ TERRITORY | XX |
FIRM NAME | Eric P. Mirabel JD LLM |
STREET | 3783 Darcus St |
CITY | Houston |
STATE | Texas |
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
ZIP/POSTAL CODE | 77005 |
PHONE | 281-772-3794 |
EMAIL ADDRESS | emirabel@comcast.net |
CORRESPONDENCE INFORMATION | |
NAME | Eric P Mirabel |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | emirabel@comcast.net |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | epmira@gmail.com |
FEE INFORMATION | |
APPLICATION FILING OPTION | TEAS Plus |
NUMBER OF CLASSES | 1 |
APPLICATION FOR REGISTRATION PER CLASS | 250 |
*TOTAL FEES DUE | 250 |
*TOTAL FEES PAID | 250 |
SIGNATURE INFORMATION | |
* SIGNATURE | /Eric Mirabel/ |
* SIGNATORY'S NAME | Eric Mirabel |
* SIGNATORY'S POSITION | attorney of record |
SIGNATORY'S PHONE NUMBER | 281-772-3794 |
* DATE SIGNED | 05/04/2022 |
SIGNATURE METHOD | Signed directly within the form |
PTO- 1478 |
Approved for use through 10/31/2024. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 97394650 |
Filing Date: 05/04/2022 |
The applicant's current Correspondence Information: |
Eric P Mirabel |
PRIMARY EMAIL FOR CORRESPONDENCE: emirabel@comcast.net SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): epmira@gmail.com Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS). |
|
|